Local pharmaceutical manufacturer targets global market with first shipment
Health & Science
By
David Njaaga
| Sep 22, 2024
A local pharmaceutical manufacturer is set to enhance Kenya’s global presence through new exports.
SQUARE Pharmaceuticals marked a milestone with its first shipment from the Athi River plant on Friday.
The flag-off ceremony included officials from SQUARE Pharmaceuticals Kenya and Export Processing Zones Authority (EPZA) Director Dr. Iruki Kailemia.
The shipment consisted of 5,500 boxes of Angilock tablets, a medication for high blood pressure that combines two ingredients to help control blood pressure levels. Somalia will be the initial destination.
“This achievement reflects our dedication to providing high-quality healthcare solutions,” Kailemia said, noting plans to supply other African and European countries from the plant.
READ MORE
China and Kenya China pledge to deepen cultural exchanges, strengthen ties
New KRA boss Muriithi wants outdated annual Finance Bill scrapped
KTDA focuses on tea quality as weekly auction generates Sh1.6 billion
Directline insurance moves to repair image amid shareholder wrangles
Kenya-UAE deal could be a catalyst for job creation and an economic booster
Survey reveals housing project has missed the mark, is doomed to fail
TikTok's US future in limbo after Supreme Court ruling
End of the road for CMC Motors as auto dealer to close shop
Prateek Suri: How the richest Indian billionaire in Africa is increasing ties through innovation
The firm has operated in Kenya since 2004, with its manufacturing facility opening in 2023.
Kailemia said the export will boost confidence in Kenyan-made pharmaceuticals among local healthcare professionals.
'This export demonstrates that local pharmaceuticals can meet international standards,” he added.
The company employs 250 local workers and plans to increase the number to 1,000 as operations grow, with plans for a line of liquid medications and injections.